Researchers Develop Innovative Approach for Muscle Tissue Regeneration

Unlike other biotech firms that rely on a combination of natural or synthetic materials along with cells to fabricate in vitro-grown tissue replacements, Evolved.Bio employs an approach that can potentially sidestep concerns associated with foreign object reactions. Traditional methods may lead to medical complications or disruptions in the body’s natural healing processes.

Evolved.Bio has developed a method for in-vitro tissue creation that addresses the aforementioned issue, offering enhanced positive outcomes for patients. This groundbreaking approach, detailed in the paper titled “Anchored Cell Sheet Engineering: A Novel Scaffold-Free Platform for in vitro Modeling,” has been published in Advanced Functional Materials.

Alireza Shahin, the Co-founder and CEO of Evolved.Bio, explained that their innovative technique enables cells to recreate all the components and structure of healthy tissue outside of the body. This approach ensures that when the in-vitro-grown tissue is implanted, it possesses all the characteristics the body anticipates. Consequently, it can guide the patient’s cells to effectively restore the tissue. Evolved.Bio is a company operating out of Velocity, the startup incubator at the University of Waterloo.

While this innovative technology is adaptable for use with any cell type and tissue, Evolved.Bio has directed its focus toward addressing volumetric muscle loss, specifically targeting skeletal muscle tissue. Skeletal muscle is the body’s largest tissue responsible for generating movement.

Shahin, expressing Evolved.Bio’s strategic approach, highlighted their initial focus on addressing volumetric muscle loss—a condition affecting a significant number of individuals annually and lacking effective treatment options. This condition results in the loss of substantial muscle mass, impairing the patient’s ability to move and generate force. The aim is for Evolved.Bio’s innovative technology to offer a valuable solution in addressing this challenging medical scenario.

Although Evolved.Bio’s co-founder John Cappuccitti acknowledged the potential applicability of their technology in various industries, including “cultivated meat” where meat protein can be generated by culturing animal cells in vitro, the primary objective remains the utilization of their muscle tissue method for regenerative medicine purposes.

Cappuccitti emphasized the limited options available in the field, citing instances where individuals underwent alternative techniques but never fully regained muscle function. Evolved.Bio aims to bring a permanent end to such suffering through their innovative approach in regenerative medicine.

Since 2021, Evolved.Bio has been situated at Velocity, and according to both co-founders, being integrated into the incubator’s network has played a pivotal role in establishing invaluable connections as the company progressed in developing its groundbreaking technology.

Cappuccitti highlighted the significant impact of being at Velocity on the development of their technology. Beyond the facilities provided, he emphasized the value derived from the presence of supportive staff and fellow founders, contributing to a collaborative environment that has proven instrumental in their technological advancements.

Resources

1. ^NEWSPAPER University of Waterloo. (2023, November 10). Scientists invent new method to regenerate muscle tissue. Phys.org. [Phys.org]
2. ^JOURNAL Shahin‐Shamsabadi, A., & Cappuccitti, J. (2023). Anchored Cell Sheet Engineering: A Novel Scaffold‐Free Platform for in vitro Modeling. Advanced Functional Materials. [Advanced Functional Materials]